Annual report pursuant to Section 13 and 15(d)

Schedule I - Condensed Statement of Cashflow

v3.8.0.1
Schedule I - Condensed Statement of Cashflow - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2016
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Cash flows from operating activities:                      
Net income (loss) $ 65,011 $ (3,345) $ (1,609) $ (2,454) $ 10,664 $ (10,017) $ (77,262) $ (3,131) $ 57,603 $ (79,746) $ 11,427
Adjustments to reconcile net income (loss) to net cash provided by operating activities:                      
Stock compensation                 8,799 5,432 2,256
Net cash provided by operating activities                 116,062 119,720 44,715
Cash flows from investing activities:                      
Net cash used in investing activities                 (182,695) (1,929,680) (38,725)
Cash flows from financing activities:                      
IPO proceeds                 507,500 0 0
IPO costs                 (26,804) 0 0
Net cash provided by (used in) financing activities                 68,944 1,861,433 (3,462)
Effect of exchange rate changes on cash and cash equivalents                 (6,858) (5,886) 0
Net change in cash and cash equivalents                 (4,547) 45,587 2,528
Cash and cash equivalents at beginning of period       70,742       25,155 70,742 25,155 22,627
Cash and cash equivalents at end of period 66,195       70,742       66,195 70,742 25,155
Parent Company                      
Cash flows from operating activities:                      
Net income (loss)                 57,603 (79,746)  
Equity in net (income) loss from subsidiaries                 (66,402) 72,717  
Adjustments to reconcile net income (loss) to net cash provided by operating activities:                      
Stock compensation                 8,799 7,029  
Net cash provided by operating activities                 0 0  
Cash flows from investing activities:                      
Investment in subsidiaries                 (480,696) 0  
Net cash used in investing activities                 (480,696) 0  
Cash flows from financing activities:                      
IPO proceeds                 507,500 0  
IPO costs                 (26,804) 0  
Net cash provided by (used in) financing activities                 480,696 0  
Effect of exchange rate changes on cash and cash equivalents                 0 0  
Net change in cash and cash equivalents                 0 0  
Cash and cash equivalents at beginning of period       $ 0       $ 0 0 0  
Cash and cash equivalents at end of period $ 0       $ 0       $ 0 $ 0 $ 0